CION Ameerpet
Immunotherapy Safety
Contraception during immunotherapy — why it is non-negotiable
Most breast and gynaecological cancer patients are never candidates for immunotherapy at all. If you are in the smaller group who is, and you can become pregnant or father a pregnancy, effective contraception is a condition of treatment — from before the first infusion until months after the last one. It is written on the consent form. It is very often never said out loud.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist · MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- Required, not advised — Effective contraception is a condition of starting checkpoint inhibitor immunotherapy, for anyone who can conceive.
- The window outlasts treatment — It continues for months after your final infusion — the part most people are never told.
- Method matters — Barrier and non-hormonal options first; cycle tracking is unusable once periods become irregular.
- Ask before cycle one — Contraception, fertility preservation and breastfeeding are three separate conversations, all easier before treatment starts.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start here
Is contraception required during immunotherapy?
Yes, for anyone who can become pregnant. Most breast and gynaecological cancer patients are never candidates for immunotherapy in the first place. If you are in the smaller group who is, effective contraception is required from before the first infusion until months after the last one.
Two things are worth separating before anything else. The first is that immunotherapy is not a general breast or gynaecological cancer treatment. NCCN, ASCO and ESMO guidance places checkpoint inhibitor immunotherapy in specific situations — defined subtypes, defined stages, and in several settings only when a biomarker test qualifies. Most women who search for it will be told it is not part of their plan, and they are still being treated properly.
The second is that if immunotherapy is in your plan, contraception stops being a lifestyle question and becomes a condition of treatment. That is the part this page exists for. The requirement is usually printed somewhere on the consent form. It is very often never spoken about in the room, particularly with younger patients, and particularly when the appointment is already carrying a diagnosis, a stage and a schedule.
The reason it is treated so firmly is mechanical rather than moral. Checkpoint inhibitor immunotherapy works by releasing a brake on your immune system so that immune cells are less restrained. The PD-1 and PD-L1 signalling pathway that these medicines block is also one of the pathways that keeps a mother’s immune system from reacting against a pregnancy. Releasing that brake deliberately, in someone who is pregnant, works against something the body needs intact.
Approved product information for this drug class therefore advises against use in pregnancy, and asks for effective contraception during treatment and for a defined period afterwards. A documented pregnancy test before the first cycle is standard practice for anyone of childbearing potential. If there is any chance you are already pregnant when immunotherapy is proposed, say so at that consultation — before treatment starts, not after.
Immunotherapy on this page means immune checkpoint inhibitors as a drug class. This page names no medicine and no brand, and it recommends no treatment. At CION, immunotherapy is given as day care at our centres when it is genuinely indicated, every plan is set by a tumour board rather than by one doctor, and any cost discussed with you is indicative, as of August 2026, and confirmed in writing before treatment starts.
Did you know?
The single most missed detail is not whether contraception is required — it is when it is allowed to stop. These medicines are antibodies with a long half-life, so meaningful drug levels remain in the body well after the final infusion. That is why approved product information asks for contraception to continue for months after treatment ends, and why “my last cycle is done” is not the same as “I can stop now”.
The timeline
How long after stopping immunotherapy must contraception continue?
Longer than treatment itself. Contraception continues through every cycle and then for a defined period after the final infusion, commonly in the region of three to five months for checkpoint inhibitor immunotherapy. If chemotherapy is part of the regimen, its own window is usually longer, and the longer one applies.
| Point in your treatment | What is required | Typical window | Where the exact figure comes from |
|---|---|---|---|
| Before the first infusion | Contraception already in place, plus a documented pregnancy test for anyone of childbearing potential. | From the consultation where immunotherapy is agreed — not from the day of cycle one. | Your medical oncologist, recorded on the consent form. |
| Through every cycle | Continuous effective contraception, with no gap while switching method. | The whole course, including any break between cycles. | Same — it should be restated at each review, and often is not. |
| After the last checkpoint inhibitor dose | Contraception continues. This is the step most often missed. | Commonly in the region of three to five months; it differs between agents in the class. | The approved product information for the specific medicine on your prescription. |
| If chemotherapy is part of the plan | The chemotherapy requirement runs in parallel and usually lasts longer. | Commonly six months or more after the last chemotherapy dose, and up to a year for some regimens. | The chemotherapy protocol; the longer of the two windows is the one that applies. |
| Male patients | Barrier contraception, especially where chemotherapy is part of the regimen. | For the whole treatment period and the months your team specifies afterwards. | Your medical oncologist — ask explicitly, it is rarely volunteered. |
| Breastfeeding | Not during treatment, and not immediately after the final dose. | A defined interval after the last dose, which differs by agent. | The approved product information, confirmed by your treating team. |
The ranges above describe what is commonly specified across this drug class. They are not your number. Every checkpoint inhibitor carries its own stated period, regimens combine medicines with different windows, and the figures are revised as product information is updated. Ask for the exact number of months for your own prescription and ask for it written on your discharge summary. A course can also run far longer than people expect — consolidation immunotherapy after chemoradiation is planned in months, not weeks, which makes contraception a long-term arrangement rather than a short one.
Why it is written so firmly
Why is this rule stricter than it sounds?
Four reasons sit behind it. Each one explains a different part of the instruction, including the part that continues after your treatment has finished.
The mechanism
The same brake protects a pregnancy
The PD-1 and PD-L1 pathway that these medicines block is one of the signals that stops a mother’s immune system reacting against a pregnancy. The treatment is designed to release that brake. In pregnancy, that is working against something the body relies on.
The biology of transfer
Antibodies cross the placenta
Checkpoint inhibitors are antibodies, and antibodies of this type are actively transported across the placenta, increasingly so from the second trimester onwards. Exposure is therefore not limited to the mother once a pregnancy is established.
The half-life
The medicine outlasts the last infusion
These are long-acting antibodies, cleared over weeks rather than days. That is precisely why the contraception window extends for months past your final cycle, and why finishing treatment does not end the requirement.
The evidence gap
The human data is genuinely thin
Pregnant women are excluded from immunotherapy trials, so what is known comes from animal studies and scattered case reports. The honest position is that the risk is not precisely quantified — which is a reason for caution, not for reassurance.
If immunotherapy has not yet been confirmed as part of your plan, start with our overview of immunotherapy at CION Cancer Clinics, which sets out where it fits and where it does not.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get the answer in writing, before cycle one
A 45-minute consultation covering contraception, fertility preservation and breastfeeding together — the three conversations that are hardest to have later.
Choosing a method
Which contraception methods are safe during immunotherapy?
Barrier methods and non-hormonal long-acting methods are the usual starting point. Condoms can be started the same day. A copper intrauterine device is highly effective but has to be inserted when your blood counts allow. Hormonal methods are a specialist decision in breast and gynaecological cancers, not a default.
| Method | Usable during immunotherapy? | What has to be checked first | Notes for breast and gynaecological patients |
|---|---|---|---|
| Condoms (male or female) | Yes — the simplest option, usable from today. | Nothing. No interaction with cancer treatment. | Also the practical answer for the short period after a chemotherapy dose when body fluids can carry drug residue. |
| Copper intrauterine device | Yes, and highly effective for years. | Insertion timing. It is a procedure, so it needs adequate platelet and neutrophil counts. | Hormone free, which is why it is often preferred here. Best placed before starting, or in a window when counts have recovered. |
| Hormone-releasing intrauterine device | Sometimes, on specialist advice. | Same insertion timing considerations, plus your specific cancer type. | A decision for your oncologist and gynaecologist together. Not something to arrange independently while on treatment. |
| Combined pill, patch or vaginal ring | Usually avoided. | Oestrogen content, and your clot risk. | Cancer itself raises the risk of clots, and oestrogen is generally avoided in hormone-sensitive breast cancer. Ask before continuing one you were already taking. |
| Progestogen-only pill, implant or injection | Sometimes, on specialist advice. | Your cancer type and hormone receptor status. | The injection can also delay the return of fertility afterwards, which matters if you are hoping to conceive later. |
| Calendar tracking, apps, withdrawal | Not adequate here. | — | Periods commonly become irregular or stop during treatment, so cycle tracking has nothing reliable to track. An absent period does not mean you cannot conceive. |
| Permanent methods (tubal ligation, vasectomy) | Possible, but rarely the right moment. | Fitness for surgery, and whether the decision is being made under time pressure. | A permanent choice made mid-diagnosis is worth deferring. Use a reversible method now and revisit it afterwards. |
| Emergency contraception | Available if a method fails. | Tell your oncology team, ideally the same day. | It is a backup, not a plan. If it has been needed once, the routine method probably needs changing. |
No method is completely reliable, which is one reason barrier contraception is often advised alongside a second method during treatment. Choose the method with your oncologist and gynaecologist together, ideally before the first cycle, and write it into your treatment file so it is not re-litigated at every review. Any charge for a device or procedure is indicative, as of August 2026, and given to you in writing beforehand.
If it happens anyway
What happens if a pregnancy occurs during immunotherapy?
Tell your oncology team the same day. Treatment is usually paused while a medical oncologist and an obstetrician review it together. Human evidence in this situation is limited, so the risk is not precisely quantified. What follows is an individual decision made with your own doctors, not a decision this page can make.
- 1
Say it out loud, today
Not at the next scheduled review. A missed period during treatment, or a positive home test, is a same-day phone call. Nothing you say will change how you are treated as a patient, and delay is the only part of this you actually control.
- 2
Treatment is paused while it is reviewed
The next cycle is held rather than given on schedule. This is a normal safety step, not a punishment and not an abandonment of your cancer treatment. It buys the time needed to make the decision properly.
- 3
Your oncologist and an obstetrician review it together
The conversation covers your cancer and its stage, how far the pregnancy has progressed, what exposure has already occurred, and what the alternatives to immunotherapy are for you. Two specialities, one discussion, rather than two separate opinions you are left to reconcile.
- 4
The decision is yours, made with information
There is no single correct answer here and no protocol that decides for you. What a good team owes you is the honest state of the evidence, the alternatives, and time. Bring your spouse or whoever supports you. This is not a conversation to have alone.
Male patients are part of this too, and are asked about it far less. Where chemotherapy is part of the regimen — as it is in most immunotherapy plans, including the combination approach described on our page about immunotherapy for small cell lung cancer — men carry their own contraception requirement during treatment and for the months afterwards. Ask for the number rather than assuming there isn’t one.
Two different conversations
Is contraception the same as protecting your fertility?
No. Contraception prevents a pregnancy during treatment. Fertility preservation protects your ability to have one afterwards. They are separate conversations, they are handled by different specialists, and only one of them has a deadline — fertility preservation usually has to happen before treatment starts.
This distinction gets lost constantly, and it costs people options. A young adult who is told “you must not get pregnant on this treatment” can reasonably hear it as a statement about their future fertility, which it is not. Equally, someone who has banked eggs or sperm can assume the fertility question is now closed and that contraception no longer applies to them, which is also wrong.
If having children later matters to you, raise it at the consultation where treatment is first proposed — not after cycle one. Egg, embryo and sperm preservation take time to arrange and are far harder to organise once treatment has begun. Where chemotherapy is part of the regimen, the effect on ovarian reserve and on sperm counts is a real consideration, and one your medical oncologist can refer on for the same week if you ask.
It is also worth naming the money question early rather than late. Fertility preservation, contraceptive devices and the treatment itself are three separate costs, and only some of them are covered by insurance or by a government scheme such as Aarogyasri, CGHS, ECHS or ESI. Our page on the cost of immunotherapy for breast and gynaecological cancers sets out how the treatment side is built up; any figure quoted to you is indicative, as of August 2026, and confirmed in writing before anything starts.
- Ask whether immunotherapy is actually part of your plan, before assuming this page applies to you at all.
- Ask for your contraception window in months, counted from your last dose, in writing.
- Ask whether fertility preservation is possible and how quickly it would have to be arranged.
- Ask which contraceptive method your oncologist and gynaecologist agree on, and when it should be started or fitted.
- Ask what happens to the schedule if a cycle is delayed, so you know the window is measured from the real last dose.
CION is a woman-headed organisation, and breast and gynaecological cancers are among the diseases our teams see most. Every consultation is 45 minutes, every plan goes to a tumour board, and infusions are given as day care at our centres. Response-assessment PET-CT is coordinated at our partner imaging centres rather than done in-house.
Next step
Have your plan reviewed before you start
Free, written, and reviewed by our tumour board — including what is required of you during treatment and for the months after it.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Contraception during immunotherapy: your questions answered
Is contraception required during immunotherapy?
Yes. For anyone who can become pregnant, effective contraception is required before the first infusion, all the way through treatment, and for a defined period after the last dose. It is a condition of treatment rather than a suggestion. Checkpoint inhibitor immunotherapy works by releasing a brake on the immune system, and the same braking signal is what allows a pregnancy to be tolerated by the mother's body. Approved product information for this drug class advises against use in pregnancy for that reason. A documented pregnancy test before the first cycle is standard practice. If there is any chance you are already pregnant, say so before treatment starts, not after.
How long after the last immunotherapy dose do you need contraception?
Longer than most people expect. Contraception has to continue for a defined period after your final infusion. It does not stop on the day treatment ends. Across approved product information for checkpoint inhibitor immunotherapy, the period specified is commonly in the region of three to five months after the last dose, and it differs between agents in the class. If chemotherapy is part of your regimen, its own requirement is usually longer, and the longer of the two is what applies to you. Ask your medical oncologist for the exact number of months for the medicine on your own prescription, and ask for it written on your discharge summary. Do not take that figure from a general article, including this one.
Which contraception methods are safe during immunotherapy?
Barrier methods and non-hormonal long-acting methods are the usual starting point. Condoms are reliable, have no interaction with cancer treatment, and can be started the same day. A copper intrauterine device is highly effective and hormone free, but the insertion has to be timed for when your blood counts are adequate, because the procedure carries infection and bleeding risk when counts are low. Hormonal contraception is a specialist decision rather than a default, particularly in breast and gynaecological cancers, where hormone exposure and clot risk both matter. Calendar tracking and withdrawal are not adequate here. Periods often become irregular or stop during treatment, which makes cycle tracking unusable, and an absent period does not mean you cannot conceive.
Do men on immunotherapy need to use contraception?
Often yes, and it is asked about far less than it should be. For checkpoint inhibitor immunotherapy given on its own, approved product information is generally less prescriptive for male patients than for female patients. Most immunotherapy regimens, however, include chemotherapy, and chemotherapy does carry a defined contraception requirement for men, during treatment and for a period afterwards. Where any doubt exists, barrier contraception for the whole treatment period and for the months your team specifies is the straightforward answer. Men who may want children later should also raise sperm banking before treatment starts. That conversation is separate from contraception and it is much harder to have once cycles have already begun.
What happens if a pregnancy occurs during immunotherapy?
Tell your oncology team the same day. A pregnancy during checkpoint inhibitor immunotherapy is treated as an urgent situation, not a routine appointment. Treatment is usually paused while your medical oncologist and an obstetrician review it together, and the discussion covers your cancer, the stage of the pregnancy, and the exposure that has already happened. Human evidence here is limited, because pregnant women are excluded from immunotherapy trials, so the honest position is that the risk is not precisely quantified. What follows is an individual decision made with your own doctors and your family. Nothing on this page is a recommendation about that decision. The one thing that genuinely helps is speaking up early.
Can you breastfeed during immunotherapy?
No, not during treatment and not immediately after it. Approved product information for checkpoint inhibitor immunotherapy advises against breastfeeding during treatment and for a period after the final dose, because it is not known how much of the antibody passes into breast milk or what it does to a feeding infant. The period specified differs by agent, so ask for the figure that applies to your own prescription. If you are breastfeeding when immunotherapy is first proposed, raise it at that consultation rather than later. There are practical alternatives, and planning them in advance is far easier than stopping abruptly mid-course.